Advertisement
PerkinElmer
PerkinElmer

Tuberculosis Trial Launched

The TB Alliance will test a new combination of drugs to combat normal and multi-drug-resistant tuberculosis.

By | March 20, 2012

WIKIMEDIA COMMONS, DVORTYGIRL

The TB Alliance is continuing its charge to develop a new drug regimen for people with tuberculosis, jumping regulatory hurdles to test several new combinations of drugs. Yesterday, the non-profit organization announced that they would begin a second clinical trial to test a new drug combination that can be taken for less time and, hopefully, work more effectively against the disease.

Currently, tuberculosis patients are prescribed a handful of antibiotics to be taken every day for 6 months. And if they develop a multi-drug-resistant form of tuberculosis, they will receive daily injections for 6 months, followed by 18 months of pill-popping.

In September 2010, the TB Alliance launched the first new phase II trial for new tuberculosis medicines in 50 years, testing a three-drug regimen: the experimental drug PA-824 with antibiotics moxifloxacin, and pyrazinamide. The first trial, completed in September 2011, only measured the drug’s safety and efficacy for 2 weeks.

The new trial will test the same drugs, but instead will last for 2 months, enroll around 250 people, and take place at 8 sites around Africa and South America.

The TB Alliance hopes that, with this drug combination, treatment time will be cut to 4 months, patients will take fewer pills, and costs will be lower.

Advertisement

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo
Advertisement
LI-COR
LI-COR

Popular Now

  1. Neanderthal-Human Hybrid Unearthed
  2. Extra DNA Base Discovered
    The Nutshell Extra DNA Base Discovered

    An epigenetic variant of cytosine is stable in the genomes of living mice, suggesting a possible expansion of the DNA alphabet.

  3. Opinion: Too Many Mitochondrial Genome Papers
  4. The Brain on Fear
    The Scientist The Brain on Fear

    Scientists uncover the neurons in the mouse brain responsible for linking the sight of a looming object to scared behavior.

Advertisement
BioLegend
BioLegend
Advertisement
The Scientist